Locally advanced breast carcinoma: Evaluation of mammography in the prediction of residual disease after induction chemotherapy

Anticancer Research

Volumn 20, Issue 1 B, 2000, Pages 553-558

  Huber, Sabine ^a   Wagner, Monika ^a   Zuna, Ivan ^b   Medl, Michael ^a   Czembirek, Heinrich ^a   Delorme, Stefan ^b  

^a GENERAL HOSPITAL LINZ   (Austria)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Breast; Breast neoplasms; Chemotherapy; Neoplasms; Radiography therapy

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAMMOGRAPHY; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CALCINOSIS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAMMOGRAPHY; MASTECTOMY; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034027684     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, Mc Neese MD, Paulus D: Management of Stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 62: 2507-2516, 1988.
2. Mansi JL, Smith IE, Walsh G, A'Hern R, Harmer C, Sinnett HD: Primary medical therapy for operable breast cancer. Eur J Cancer Clin Oncol 25(11): 1623-1627, 1989.
3. Bonadonna G, Veronesi U, Brambilla CM, Ferrari L, Luini A, Greco: Primary chemotherapy to avoid mastectomy in tumours with diameters of 3 centimetres or more. J Natl Cancer Inst 82: 1539-1545, 1990.
4. Valagussa P, Zambetti M, Bonadonna G, Zucali R, Mezzanotte G, Veronesi U: Prognostic factors in locally advanced noninflammatory breast cancer. Long term results following primary chemotherapy. Breast Cancer Res Treatment 15: 137-147, 1990.
5. Anderson EDC, Forrest APM, Hawkins RA, Anderson TJ, Leonard RCF, Chetty U: Primary systemic therapy for operable breast cancer. Br J Cancer 63: 561-566, 1991.
6. Jodrell DI, Smith IE, Mansi JL, Pearson MC, Walsh G, Ashley S: A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM)and cyclophosphamide/ methotrexate/5FU (CMF) in the treatment of advanced breast cancer. Br J Cancer 63: 794-798, 1991.
7. Hayward LJ, Carbone PP, Hewson JC: Assessment of response to therapy in advanced breast cancer. Br J Cancer 35: 292-301, 1977.
8. Fisher B, Gebhardt M: The evolution of breast cancer surgery: past, present and future. Semin Oncol 5: 385-394, 1987.
9. Ragaz J , Blaird R, Rebbeck P, Goldie J, Coldman A, Spinelli J: Neoadjuvant (pre-operative) chemotherapy for breast cancer. Cancer 56: 719-729, 1985.
10. Feldman LD, Hortobagyi GN, Buzdar AU, Ames FC, Blumenschein GR: Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 46: 2578-2581, 1986.
11. Powles TJ, Ashley SE, Makris A: A randomised trial of chemoendocrine therapy started before (neoadjuvant) or after (adjuvant) surgery for treatment of primary breast cancer. J Clin Oncol 13: 547-552, 1995.
12. Bloomer WD, Berenberg AL, Weissmann BN: Mammography of the definitively irradiated breast. Radiology 118: 425-428, 1976.
13. Segel MC, Paulus DD, Hortobagyi GN: Advanced primary breast cancer: assessement at mammography of response to induction chemotherapy. Radiology 169: 49-54, 1988.
14. Rouesse J, Friedman S, Sarrazin D: Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol 4: 1765-1771, 1986.
15. Swain SM, Sorace RA, Bagley CS: Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 47: 3889-3894, 1987.
16. Jacquillat C, Weil M, Baillet F: Results of neoadjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 66: 119-129, 1990.
17. Polyzos A, Markopoulos C, Dardoufas K: Locally advanced breast cancer: application of all available therapeutic modalities. Breast Dis 8: 235-241, 1995.
18. Pierce LJ, Lippmann M, Ben-Baruch N: The effect of systemic therapy on local-regional control in locally advanced breast cancer. Int J Radiat Oncol Biol Phys 23: 949-960, 1992.
19. Hortobagyi GN, Blumenschein GR, Spanos W: Multimodality treatment of locoregionally advanced breast cancer. Cancer 51: 763-768, 1983.
20. Hortobagyi GN, Spanos W, Montague ED, Buzdar AV, Yap HY, Blumenschein GR: Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy. Int J Radiat Oncol Biol Phys 9: 543-650, 1984.
21. Sponzo RW, Cunningham TJ, Caradonna RR. Management of non-resectable (stage III) breast cancer. Int J Radiat Oncol Biol Phys 5: 1475-1478, 1979.
22. Sorace RA, Bagley CS, Lichter AS: Management of non-metastastic locally advanced hormonal synchronization followed by radiation therapy with or without debulking surgery. World J Surg 9: 755-785, 1985.
23. Sauven P, Grant R, Burns I: The role of mammography in the evaluation of advanved breast cancer treated by initial endocrine therapy. Br J Surg 70: 453-456, 1983.
24. Singletary SE, Mc Neese MD, Hortobagyi GN: Feasibility of breast conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 69: 2849-2852, 1992.
25. Fornage BD, Toubas O, Morel M: Clinical, mammographic and sonographic determination of pre-operative breast cancer size. Cancer 60: 765-771, 1987.
26. Cocconi G, DiBlasio B, Alberti G, Bisagni G, Botti E, Peracchis G: Problems in evaluation response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 4: 309-313, 1984.
27. Forrest APM, Levack PA, Chetty U, Hawkins RA, Miller WR, Smyth JF, Anderson TJ: A human tumour model. Lancet ii; 840-842, 1986.
28. Pierce L, Adler D, Licter A, Merajver S: The use of mammography in breast preservation in locally advanced breast cancer. Int J Radiat Oncol Biol Phys 34: 3, 571-7, 1996.
29. Holland R, Hendriks JHCL, Mravunac M: Mammographically occult breast cancer. Cancer 52: 1810-1819, 1983.
30. Libshitz HI: Diagnostic roentgenology of radiotherapeutic change. In: Breast, Ch. 5 (Paulus DD&Lipshitz HI, eds). Baltimore, Williams*Wilkins, 1979, pp 55-68.
31. Libshitz HI, Montague ED, Paulus DD: Calcifications and the therapeutically irradiated breast. AJR 128: 1021-1025, 1977.
32. Kennedy S, Merino MJ, Swain SM, Lippman ME: The effects of hormonal and chemotherapy on tumoral and non-neoplastic breast tissue. Human Pathology 21: 192-198, 1990.
33. Moskovic EC, Mansi JL, King DM, Murch CR, Smith IE: Mammography in the assessment of response to medical treatment of large primary breast cancers. Clin Radiol 47: 339-344, 1993.
34. Vinnicombe SJ, MacVicar AD, Guy RL, Sloane JP, Powles TJ, Knee G, Husband JE: Primary breast cancer: Mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 198: 333-340, 1996.